Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-07 Sale | 2024-03-08 5:28 pm | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 13,000 | $46.28 | $601,615 | 2,000 (Direct) | View |
| 2022-08-11 Purchase | 2022-08-11 4:19 pm | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 44,400 | $2.03 | $90,132 | 56,400 (Direct) | View |
| 2021-08-23 Purchase | 2021-08-23 6:28 pm | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 2,829 | $7.985 | $22,590 | 12,000 (Direct) | View |
| 2021-08-18 Purchase | 2021-08-20 4:10 pm | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 3,171 | $8.05 | $25,527 | 9,171 (Direct) | View |
| 2021-08-16 Purchase | 2021-08-17 4:05 pm | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 6,000 | $8.1 | $48,600 | 6,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-04 Disposition | 2024-06-04 5:31 pm | N/A N/A | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 278,411 | $0 | 0 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-14 5:07 pm | N/A 2033-06-13 | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-02 5:25 pm | N/A 2033-06-01 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 18,475 | $0 | 18,475 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:26 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-22 7:09 pm | N/A 2032-06-13 | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 4:15 pm | N/A 2031-06-03 | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:04 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-01-19 Option Award | 2020-06-30 06:49 am | N/A 2030-01-19 | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 171,011 | $0 | 171,011 (Direct) | View |
Ownership | 2020-06-25 8:02 pm | N/A 2030-01-19 | Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director | 0 | $0 | 141,011 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 5:00 pm | N/A 2030-05-31 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 10,000 | $0 | 10,000 (Direct) | View |